Monthly Wegovy Costs & BMI Eligibility Made Simple
Wegovy BMI Requirements and Monthly Cost Planning
The Wegovy BMI requirements are straightforward: adults need a BMI of 30 or above, or a BMI of 27 or above with weight-related health conditions such as high blood pressure or type 2 diabetes. When considering these Wegovy BMI requirements, understanding monthly costs becomes essential for long-term treatment planning. Your monthly investment varies significantly during the 16-week dose escalation period, starting at just £79.99 for the initial 0.25mg dose and progressing to £209.99 for the maintenance 2.4mg dose.
Meeting Wegovy BMI requirements means committing to a structured treatment protocol that spans months, not weeks. The monthly cost structure reflects this gradual approach: weeks 1-4 cost £79.99, weeks 5-8 cost £94.99, weeks 9-12 cost £99.99, weeks 13-16 cost £139.99, and maintenance from week 17 onwards costs £209.99 monthly. This escalation ensures your body adapts gradually whilst managing your monthly budget predictably throughout your journey.
Pricing Structure for Wegovy BMI-Qualified Patients
For patients meeting Wegovy BMI requirements, our pricing structure offers exceptional value through bundled options and discount codes. New customers receive code FIRST40 at checkout, whilst returning customers benefit from DOSE25 for ongoing savings. The Intro Duo bundle (0.25mg & 0.5mg pens) costs £169.99, covering your first two months of treatment once you've satisfied the Wegovy BMI requirements through our clinical assessment.
Our Ultimate Stability Trio provides three months of maintenance 2.4mg supply for £649.99, offering convenience and supply security for established patients. The annual maintenance cost totals approximately £2,519.88 (£209.99 × 12 months), making Wegovy a significant but manageable investment in your health. These transparent prices eliminate surprises and help you budget effectively once you've confirmed you meet the Wegovy BMI requirements.
Clinical Evidence Supporting Wegovy BMI Requirements
The established Wegovy BMI requirements stem from extensive clinical research, particularly the landmark STEP trials. In STEP 1, patients meeting these BMI criteria and taking Wegovy alongside a reduced-calorie diet and increased physical activity achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). These results validated the current BMI thresholds for treatment eligibility.
STEP 5 demonstrated that patients meeting Wegovy BMI requirements maintained approximately clinically studied weight loss at two years, justifying the long-term monthly investment. The SELECT trial further showed a 20% reduction in major cardiovascular events among eligible patients, reinforcing why these specific BMI criteria ensure appropriate candidate selection for this prescription-only medicine.
How Wegovy Works for BMI-Eligible Patients
Once you meet the Wegovy BMI requirements, this GLP-1 receptor agonist works by mimicking your body's natural fullness hormone, reducing appetite and promoting satiety after smaller meals. The medication targets brain appetite centres, potentially reducing food cravings that contribute to weight gain in patients with elevated BMIs. This mechanism explains why gradual dose escalation is essential – your appetite regulation systems need time to adapt to the medication's effects. The FlexTouch pen delivery system ensures precise dosing throughout your treatment journey. This biological approach to appetite control makes Wegovy particularly effective for patients meeting the established BMI criteria who struggle with traditional diet and exercise approaches alone.
Ordering Process for Wegovy BMI Assessment
Determining if you meet Wegovy BMI requirements begins with our comprehensive 3-minute online clinical assessment, which calculates your BMI and evaluates weight-related health conditions. Our prescribers review your assessment within three working days (or 24 hours with express service), confirming your eligibility against the established BMI criteria. Once approved, your Wegovy ships via next-day delivery using cold-chain temperature-controlled transport to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures all prescriptions meet MHRA guidelines for patients meeting Wegovy BMI requirements. The entire process from assessment to delivery typically takes 4-5 working days, getting you started on your weight management journey quickly and safely.
Storage and Practical Considerations for BMI-Qualified Patients
Patients meeting Wegovy BMI requirements must store their medication correctly to maintain efficacy throughout their monthly treatment cycle. Keep unused pens refrigerated at 2-8°C, though each pen can remain at room temperature below 30°C for up to six weeks once removed from the fridge – a significant advantage over competitors. The FlexTouch pen system simplifies weekly injections, rotating between thigh, abdomen, or upper arm injection sites. Each pen contains four doses, lasting exactly one month at your prescribed strength during the escalation protocol. Proper storage ensures you receive full therapeutic benefit throughout your treatment journey, maximising your monthly investment in this prescription-only medicine.
Budget Planning for Long-Term Wegovy BMI Treatment
Meeting Wegovy BMI requirements signals the start of a long-term financial commitment that requires careful monthly budgeting. The total cost for your first 16 weeks of escalation reaches £414.96 (£79.99 + £94.99 + £99.99 + £139.99), representing your initial investment in establishing therapeutic levels. From month five onwards, maintenance therapy costs £209.99 monthly, totaling £2,519.88 annually at the 2.4mg dose.
Smart patients meeting Wegovy BMI requirements often utilise our bundle options to reduce ordering frequency and ensure supply continuity. The Consistency 2.4mg bundle provides two months of maintenance supply for £419.99, whilst our Ultimate Stability Trio covers three months for £649.99. These bundles eliminate monthly reordering whilst providing supply security, particularly important given the global demand for this prescription-only medicine among qualified candidates.
Securing Your Wegovy Supply After BMI Qualification
Once you've satisfied Wegovy BMI requirements and experienced the medication's benefits, maintaining consistent supply becomes crucial for sustained results. Our returning customer code DOSE25 ensures continued affordability, whilst bundle options provide supply security without monthly reordering stress. The Ultimate Stability Trio ensures three months of uninterrupted treatment, eliminating concerns about stock shortages or delivery delays that could disrupt your progress.
Many patients meeting Wegovy BMI requirements find that supply consistency directly impacts their weight management success. Interrupting treatment often leads to appetite return and potential weight regain, making reliable monthly supply essential. Our cold-chain delivery system and GPhC registration (#9012878) ensure every pen arrives in optimal condition, ready to support your continued progress. Start your assessment today at https://everydaymeds.co.uk/collections/wegovy using code FIRST40 for new customers, and experience the difference transparent pricing and reliable supply make in your weight management journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
